四维血流MRI预测肝硬化患者轻微肝性脑病
该前瞻性研究纳入72例肝硬化伴自发性门体分流患者，基于4D flow MRI测量分流血流指标并结合临床因素构建预测模型。结合临床与4D flow参数的ModelC+H预测MHE的AUC达0.97，优于单独临床模型（0.77）或血流模型（0.90），校准良好且净临床获益最高。
要点
- 4D flow MRI可定量自发性门体分流（胃食管、脾肾/胃肾）及脾静脉、肠系膜上静脉血流。
- Child-Pugh C级、分流总截面积、F-GES、F-SRS/F-GRS及F-SV为MHE影响因素。
- 临床+4D flow联合模型对MHE预测效能最高（AUC 0.97）。
核心结论
- 4D flow MRI能揭示肝硬化患者自发性门体分流的血流动力学特征，基于其血流指标与临床因素构建的联合模型对MHE具有优秀预测性能，有助于早期发现和及时干预。
研究设计与样本
- 所有患者接受门静脉血管4D flow MRI检查，测量分流（胃食管分流F-GES、脾肾/胃肾分流F-SRS/F-GRS）、脾静脉（F-SV）和肠系膜上静脉（F-SMV）血流指标。
- 同时收集增强CT上自发性门体分流总截面积（TA-S）、人口学特征和临床因素，将患者分为MHE组（27例）和非MHE组（45例）。
- 构建临床、形态学、血流动力学及联合预测模型（ModelC、ModelM、ModelH、ModelC+H），评估其区分度、校准度和净临床获益。
诊断标准与关键数值
- Child-Pugh C级、TA-S、F-GES、F-SRS/F-GRS和F-SV为MHE的影响因素。
- 联合ModelC+H（整合临床因素与4D flow参数）预测MHE的AUC为0.97，显著优于单独临床模型（AUC 0.77）和单独血流模型（AUC 0.90）。
- ModelC+H校准良好（χ²=14.80，p=0.35），且净临床获益最高。
临床应用与阅片要点
- 在肝硬化伴自发性门体分流患者中，可考虑应用4D flow MRI定量分流血流指标（F-GES、F-SRS/F-GRS、F-SV）辅助MHE风险评估。
- 联合临床因素（如Child-Pugh分级）与4D flow血流参数可提高MHE预测效能，优于单独使用任一类型数据。
- 增强CT上自发性门体分流总截面积（TA-S）也与MHE相关，阅片时可关注分流的形态学负荷。
局限性
- 单中心前瞻性研究，样本量较小（共72例，MHE组27例）。
- 原文未报告外部验证队列，联合模型的泛化能力有待进一步验证。
以上解读依据论文摘要（全文未开放获取或许可不允许翻译转载）。
英文原文（摘要）· 点击展开
OBJECTIVES: To develop a noninvasive predictive model for minimal hepatic encephalopathy (MHE) according to the blood flow indices of spontaneous portosystemic shunt (SPSS) on four-dimensional (4D) flow MRI in patients with liver cirrhosis.
METHODS: A consecutive cohort of patients with liver cirrhosis complicated with enhanced abdominal CT-confirmed SPSS from April 2022 to October 2023 was prospectively recruited and divided into MHE and non-MHE groups. All patients underwent portal vascular imaging with 4D flow MRI, the blood flow indices of SPSSs (mainly including gastroesophageal shunts (F-GES) and splenorenal/gastrorenal shunts (F-SRS/F-GRS)), the splenic vein (F-SV), and the superior mesenteric vein (F-SMV) were measured. Additionally, the total crosssectional area of the SPSSs (TA-S) on enhanced CT, demographic characteristics and clinical factors were collected. Clinical, morphological, hemodynamic, and combined predictive models (ModelC, ModelM, ModelH, and ModelC+H) were developed. Their discrimination, calibration and net clinical benefit were evaluated to determine the value of 4D flow MRI-based hemodynamic assessment and to identify the optimal predictive model for MHE.
RESULTS: A total of 72 patients (mean age 53.9 ± 8.0 years, 43 males) were included, with 27 in the MHE group and 45 in the non-MHE group. Child-Pugh class C, TA-S, F-GES, F-SRS/F-GRS and F-SV were factors influencing the presence of MHE. The combined ModelC+H, integrating clinical factors and 4D flow parameters, substantially outperformed models based on either data type alone (AUC 0.97 vs. 0.77 and 0.90), demonstrating the complementary value of clinical and hemodynamic information. The model also exhibited good calibration (χ² = 14.80, p = 0.35) and the highest net clinical benefit, confirming its excellent predictive performance for MHE.
CONCLUSION: 4D flow MRI can reveal the hemodynamic characteristics of SPSSs in patients with liver cirrhosis, and a prediction model based on its hemodynamic index and clinical factors can provide valuable insights for early detection and serving as a clinical foundation for timely intervention in MHE.
引用
- Li X, Li X, Zheng Y, et al. Four-dimensional flow MRI-based prediction of minimal hepatic encephalopathy in patients with liver cirrhosis. Abdom Radiol (NY). 2026. PMID: 42089989. doi:10.1007/s00261-026-05539-5
供执业医师工作参考，不替代临床判断；数值与分级以指南原文为准。